Premium
CHLOROQUINE‐RESISTANT FALCIPARUM MALARIA FROM PAPUA NEW GUINEA AND ITS IMPLICATIONS FOR AUSTRALIA
Author(s) -
Hennessy W. B.,
Moodie P. M.,
Black Robert H.
Publication year - 1977
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1977.tb130461.x
Subject(s) - chloroquine , malaria , chemoprophylaxis , new guinea , plasmodium falciparum , pyrimethamine , sulfadoxine , medicine , drug resistance , drug , intensive care medicine , immunology , pharmacology , biology , microbiology and biotechnology , ethnology , history
There is need for effective chemoprophylaxis against chloroquine‐resistant falciparum malaria, and for a safe and effective drug to be readily available for the treatment of that condition. Experience with the cases cited in this study indicates that Fansidar should be made available for treatment and it is suggested that Maloprim be made available as a prophylactic agent.